114 related articles for article (PubMed ID: 12769116)
21. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
Emmer S; Allendorf L
J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
[No Abstract] [Full Text] [Related]
22. Medicare's new drug plan: the right choice for you?
Consum Rep; 2005 Dec; 70(12):8. PubMed ID: 16299949
[No Abstract] [Full Text] [Related]
23. Medigap coverage and Medicare spending: a second look.
Lemieux J; Chovan T; Heath K
Health Aff (Millwood); 2008; 27(2):469-77. PubMed ID: 18332504
[TBL] [Abstract][Full Text] [Related]
24. States' control of prescription drug spending: a heterogeneous approach.
Morden NE; Sullivan SD
Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
[TBL] [Abstract][Full Text] [Related]
25. Inequality in health insurance reform: are the elderly more at risk?
Phillips CR; Schuler DK; Jacobs EW
J Health Care Mark; 1994; 14(4):14-9. PubMed ID: 10154632
[No Abstract] [Full Text] [Related]
26. Medicare prescription drug benefit variations.
Manag Care Interface; 1999 Oct; 12(10):36. PubMed ID: 10623003
[No Abstract] [Full Text] [Related]
27. The Medicare prescription drug plan: assisting our older patients.
Klein MN
ORL Head Neck Nurs; 2004; 22(4):34-5. PubMed ID: 15617318
[TBL] [Abstract][Full Text] [Related]
28. Medicare supplement products.
Gonser G
J Mass Dent Soc; 2002; 50(4):42. PubMed ID: 12874911
[No Abstract] [Full Text] [Related]
29. The private health insurance choices of medicare beneficiaries: how much does price matter?
Rice T; Jacobson G; Cubanski J; Neuman T
Med Care Res Rev; 2014 Dec; 71(6):661-89. PubMed ID: 25371217
[TBL] [Abstract][Full Text] [Related]
30. Assessing Medicare prescription drug plans in four states: balancing cost and access.
Heaton E; Carino T; Dix H
Issue Brief (Commonw Fund); 2006 Aug; 22():1-14. PubMed ID: 16933399
[TBL] [Abstract][Full Text] [Related]
31. Means-testing in Medicare.
Pauly MV
Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-546-57. PubMed ID: 15590720
[TBL] [Abstract][Full Text] [Related]
32. Medicare extra: a comprehensive benefit option for Medicare beneficiaries.
Davis K; Moon M; Cooper B; Schoen C
Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-442-54. PubMed ID: 16204334
[TBL] [Abstract][Full Text] [Related]
33. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
AVMA Group Health & Life Insurance Trust
J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
[No Abstract] [Full Text] [Related]
34. A first look at the new Medicare prescription drug plans.
Frakt AB; Pizer SD
Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
[TBL] [Abstract][Full Text] [Related]
35. Effects of generic-only drug coverage in a Medicare HMO.
Christian-Herman J; Emons M; George D
Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-455-68. PubMed ID: 15471765
[TBL] [Abstract][Full Text] [Related]
36. New research highlights effects of Medigap reform.
Austin B; DeFrancesco L
Find Brief; 2003 Oct; 6(4):1-5. PubMed ID: 14556301
[No Abstract] [Full Text] [Related]
37. Part I--Medicare prescription drug coverage (Part D): the promise.
Witten B
Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
[No Abstract] [Full Text] [Related]
38. How do seniors use their prescription drug discount cards?
Thomas CP; Wallack SS; Martin TC
Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-180-W5-190. PubMed ID: 15840627
[TBL] [Abstract][Full Text] [Related]
39. Incentives in the Medicare prescription drug benefit.
Natl Bur Econ Res Bull Aging Health; 2006; (15):1-2. PubMed ID: 16805056
[No Abstract] [Full Text] [Related]
40. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database.
Manack A; Motsko SP; Haag-Molkenteller C; Dmochowski RR; Goehring EL; Nguyen-Khoa BA; Jones JK
Neurourol Urodyn; 2011 Mar; 30(3):395-401. PubMed ID: 20882676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
